NCT05067231 CARBON: UAB Cardiovascular Research Biobank
| NCT ID | NCT05067231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Natriuretic Peptides |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal information on a large number of people over time. It will be set up so that it can be used in the future as a resource for researchers undertaking a wide range of medical research.
Eligibility Criteria
Inclusion Criteria: * Age more than or equal to 18 Exclusion Criteria: * Age \<18, at screening * Employees or students associated with the Division of Cardiovascular Disease at UAB will not be recruited due to their vulnerable status and susceptibility to coercion. * Women who are pregnant or who can become pregnant and not practicing an acceptable method of birth control.
Contact & Investigator
Pankaj Arora, MD, FAHA
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT05067231 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Natriuretic Peptides. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05067231 currently recruiting?
Yes, NCT05067231 is actively recruiting participants. Contact the research team at nvekariya@uabmc.edu for enrollment information.
Where is the NCT05067231 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT05067231 clinical trial?
NCT05067231 is sponsored by University of Alabama at Birmingham. The principal investigator is Pankaj Arora, MD, FAHA at University of Alabama at Birmingham. The trial plans to enroll 500 participants.